Chemotherapy-Induced Thrombocytopenia Market Set to Boom Globally | Key Players Driving Growth Market Overview
The Global Chemotherapy-Induced Thrombocytopenia Market reached US$ 1,800 million in 2023 and is expected to reach US$ 3,200 million by 2031, growing with a CAGR of 7.4% during the forecast period 2024-2031. Chemotherapy-induced thrombocytopenia involves low platelet counts from treatments, raising bleeding risks. Rising cancer cases, 2.74 million new in 2022, heighten CIT...
0 Shares
518 Views
0 Reviews